Cambridge Cancer Genomics YC Başvurusu

Summer 2017Inactive

Cambridge Cancer Genomics, Healthcare şirketi olarak Summer 2017 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.

YC grubu: Summer 2017
Sektör: HealthcareDiagnostics
Ekip büyüklüğü: 25
Durum: Inactive
Lansmanı Yapıldı: 2017

Kurucular

John CassidyFounder/CEO
Nirmesh PatelFounder/Chief Scientific Officer
Evaline TsaiFounder/CPO

Cambridge Cancer Genomics ne yapar

CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. ‍ We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. We are expanding our team in Cambridge, UK, offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role. We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive the business forward. In exchange, we offer a competitive salary with performance related bonuses and stock options, alongside excellent career development opportunities in a fast-growing start-up with a chance to truly impact how cancer is treated. To apply, please send your CV to

Cambridge Cancer Genomics'in YC başvurusu, yeniden yapılandırılmış

Y Combinator başvurusu

Cambridge Cancer Genomics, Summer 2017 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Cambridge Cancer Genomics

Describe what your company does in 50 characters or less.

Personalized cancer treatment planning software

What is your company going to make? Please describe your product and what it does or will do.

We build software that helps oncologists interpret clinical and genomic data to pick the right drug for each cancer patient. Our platform analyzes patient biomarkers and treatment responses to guide precision oncology decisions.

Where do you live now, and where would the company be based after YC?

We currently live and work in Cambridge, England, United Kingdom, and the company remains based there.

Explain your decision regarding location.

Cambridge has the scientific and clinical expertise in genomics and oncology we need. Being close to hospitals and research centers allows faster collaboration and product validation.

Tam başvuruda 21 ek cevap

Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.

Tüm başvuruyu gör

Sıkça Sorulan Sorular

Bu, Cambridge Cancer Genomics şirketinin gerçek YC başvurusu mu?

Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, Cambridge Cancer Genomics'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. Cambridge Cancer Genomics gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.

Cambridge Cancer Genomics hangi YC grubundaydı?

Cambridge Cancer Genomics, Y Combinator Summer 2017 grubundaydı.

Cambridge Cancer Genomics kim tarafından kuruldu?

Cambridge Cancer Genomics, John Cassidy, Nirmesh Patel, Evaline Tsai tarafından kuruldu.

Cambridge Cancer Genomics ne iş yapar?

CCG.ai empowers clinicians to make personalised treatment strategies…

Tam yeniden oluşturulmuş başvuruyu nasıl okurum?

Ücretsiz bir Round Funded hesabı oluşturun. Cambridge Cancer Genomics'ın başvurusunun tam 26 soruluk versiyonu ve diğer tüm YC batch'leri YC Insights'ta.